ArticleScientific reports2026
Prevalence and determinants of human papillomavirus vaccine hesitancy among parents of young girls in Morocco.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
The vaccination against Human papillomavirus (HPV) effectively prevents cervical cancer, nevertheless, parental hesitancy limits coverage and reduces the impact of prevention programs. This study sought to estimate the prevalence of parental hesitancy toward HPV vaccination in Morocco and to identify the factors associated with it. A multicenter cross-sectional survey was conducted between March and September 2025 among parents of girls aged 11-14 years attending healthcare centers in Morocco. Trained interviewers administered a structured questionnaire to collect data on socioeconomic characteristics, knowledge of cervical cancer and HPV vaccination, trust in the healthcare system, social influences, and perceptions of HPV infection. We then applied multivariate logistic regression to identify factors associated with vaccine hesitancy. Data were analyzed using Epi Info™ software, version 7.2.0.1. A total of 2,088 parents with an average age of 37.9 ± 6.3 years were surveyed. Among these parents, 1,771 stated that they were hesitant to have their daughters vaccinated, representing a prevalence of 84.8% (1,771/2,088). Factors significantly associated with hesitancy included lack trust in the healthcare system (Adjusted Odds Ratio (AOR) 17.23; 95% CI [4.31-68.8]; p-value = 0.0001), low trust in the healthcare system (AOR 1.91; 95% CI [1.21-3.02]; p = 0.004), absence of recommendation from healthcare professionals (AOR 6.8; CI [2.99-15.47]; p < 0.001), not having ever heard of cervical cancer (AOR 2.94; CI [1.71-5.07]; p = 0.0001), negative media influences (AOR 2.68; CI [1.53-4.68]; p = 0.0005), societal norms (AOR 2.68; CI [1.68-4.30]; p < 0.01), low perception of HPV severity (AOR 2.58; CI [1.22-5.43]; p = 0.01), concerns about adverse reactions (AOR 2.34; CI [1.39-3.94]; p = 0.01), walking to the health center (AOR 2.23; CI [1.54-3.23]; p < 0.001), rural residence (AOR 2.01; CI [1.37-2.95]; p = 0.0004), and limited knowledge of cervical cancer complications (AOR1.88; CI [1.15-3.07]; p = 0.01). Higher monthly income was protective against hesitancy (AOR 0.39; CI [0.25-0.62]; p = 0.0001). Parental hesitancy toward HPV vaccination in Morocco is shaped by social, knowledge, and access factors. Addressing these barriers requires a comprehensive approach, including education and awareness campaigns, bolstering healthcare trust, improving access to vaccination services, and community mobilization to promote vaccine adoption.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.